Background: Brain radiotherapy is the usual remedy possibility for a number of mind metastases (BMs) from non-small cell lung most cancers (NSCLC), particularly in the absence of a driver mutation. However, the prognosis for such sufferers stays poor. Apatinib is a potent antiangiogenic compound directed on the vascular endothelial progress issue receptor-2 (VEGFR-2); nevertheless, to date, there are not any investigations of apatinib concurrent with mind radiotherapy for NSCLC sufferers with BMs.
We report a case of EGFR wild-type and ALK-negative lung adenocarcinoma affected person with a number of symptomatic BMs, who obtained apatinib along with mind radiation remedy. A positive oncologic consequence was achieved for each mind metastatic lesions and the first pulmonary tumor. Case Presentation: A 61-year-old feminine (by no means smoker) who initially offered with headache and dizziness was recognized with lung adenocarcinoma with a number of mind metastasis (cT2aN3M1b stage IV), and was unfavorable for EGFR and ALK.
The affected person refused to obtain chemotherapy and was solely amenable to mind radiotherapy and focused remedy. After approval from the institutional ethics committee, she underwent concurrent oral apatinib (500 mg/day) with complete mind radiation remedy (WBRT) (37.5Gy) with simultaneous in-field increase (49.5Gy) in 15 fractions with picture guided intensity-modulated radiotherapy.
Three weeks later, neurologic signs totally ceased and a partial response (PR) for the BMs with near-complete decision of peritumoral mind edema was achieved. Chest CT carried out on the identical time and confirmed shrinkage of the lung main with a PR.
The affected person suffered grade III oral mucositis one week after mind radiotherapy and refused additional apatinib. At 12 months after mind radiotherapy, the mind tumors remained properly managed. Conclusions: This is the primary identified documentation of a speedy medical response of apatinib concurrent with mind radiotherapy in a lung adenocarcinoma affected person with symptomatic a number of BMs. Apatinib mixed with mind radiotherapy could possibly be another remedy possibility for BMs from NSCLC, particularly for these with no driver mutation. Further medical trials are required to corroborate this discovery.
Pattern of Pediatric Supracondylar Fracture Operated at A Rural Teaching Hospital of Nepal: A Descriptive Cross-sectional Study.
Supracondylar fracture of humerus is likely one of the frequent pediatric fractures encountered in our every day medical observe. The goal of this examine is to decide the sample of supracondylar fracture operated at rural educating hospital of Jumla, Karnali Nepal.A descriptive cross sectional examine was carried out at Jumla, Karnali after Institutional Review Committee approval.
Operating room notes from 15 May 2017 to 16 November 2019 had been retrieved to collect the next data: sufferers tackle, age, intercourse, aspect, harm mechanism, displacement, neurovascular harm, concurrent accidents, preliminary administration by conventional bone setters, time between harm and surgical procedure, operative method.
NOD2 antibody |
|||
| 70R-18913 | Fitzgerald | 50 ul | 522 EUR |
|
Description: Rabbit polyclonal NOD2 antibody |
|||
Nod2 antibody |
|||
| 10R-6553 | Fitzgerald | 100 ug | 522 EUR |
|
Description: Rat monoclonal Nod2 antibody |
|||
NOD2 Antibody |
|||
| 24158-100ul | SAB | 100ul | 468 EUR |
NOD2 Antibody |
|||
| 24159-100ul | SAB | 100ul | 468 EUR |
NOD2 Antibody |
|||
| 2511-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease. |
|||
NOD2 Antibody |
|||
| 2511-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease. |
|||
NOD2 Antibody |
|||
| 2513-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease. |
|||
NOD2 Antibody |
|||
| 2513-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease. |
|||
NOD2 Antibody |
|||
| 37460-100ul | SAB | 100ul | 302.4 EUR |
NOD2 Antibody |
|||
| 1-CSB-PA015915GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
NOD2 Antibody |
|||
| 1-CSB-PA876985 | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100 |
|||
NOD2 Antibody |
|||
| 1-CSB-PA881021LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
NOD2 Antibody |
|||
| 1-CSB-PA446192 | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
|||
NOD2 Antibody |
|||
| DF12125 | Affbiotech | 200ul | 420 EUR |
NOD2 Antibody |
|||
| R34436-100UG | NSJ Bioreagents | 100 ug | 339.15 EUR |
|
Description: Additional name(s) for this target protein: Nucleotide-binding oligomerization domain-containing protein 2, caspase recruitment domain family, member 15; CARD15 |
|||
NOD2 Rabbit pAb |
|||
| A15992-100ul | Abclonal | 100 ul | 369.6 EUR |
NOD2 Rabbit pAb |
|||
| A15992-200ul | Abclonal | 200 ul | 550.8 EUR |
NOD2 Rabbit pAb |
|||
| A15992-20ul | Abclonal | 20 ul | 219.6 EUR |
NOD2 Rabbit pAb |
|||
| A15992-50ul | Abclonal | 50 ul | 267.6 EUR |
NOD2 Blocking Peptide |
|||
| DF12125-BP | Affbiotech | 1mg | 234 EUR |
Polyclonal NOD2 Antibody |
|||
| APR06297G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD2 Antibody |
|||
| APR06298G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 . This antibody is tested and proven to work in the following applications: |
|||
NOD2 Conjugated Antibody |
|||
| C37460 | SAB | 100ul | 476.4 EUR |
Human NOD2 ELISA KIT |
|||
| ELI-23582h | Lifescience Market | 96 Tests | 988.8 EUR |
Mouse Nod2 ELISA KIT |
|||
| ELI-44123m | Lifescience Market | 96 Tests | 1038 EUR |
NOD2 ELISA KIT|Human |
|||
| EF001273 | Lifescience Market | 96 Tests | 826.8 EUR |
Bovine NOD2 ELISA KIT |
|||
| ELI-22273b | Lifescience Market | 96 Tests | 1113.6 EUR |
Human NOD2 shRNA Plasmid |
|||
| 20-abx961935 | Abbexa |
|
|
TLR2 & NOD2-Based Adjuvant |
|||
| VAdv-Ly0016 | Creative Biolabs | 5 mg | 4016.4 EUR |
|
Description: A TLR2 & NOD2-based vaccine adjuvant. |
|||
NOD2 Antibody, HRP conjugated |
|||
| 1-CSB-PA881021LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
NOD2 Antibody, FITC conjugated |
|||
| 1-CSB-PA881021LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
NOD2 Antibody, Biotin conjugated |
|||
| 1-CSB-PA881021LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Nod2 ORF Vector (Rat) (pORF) |
|||
| ORF071395 | ABM | 1.0 ug DNA | 607.2 EUR |
NOD2 ORF Vector (Human) (pORF) |
|||
| ORF026166 | ABM | 1.0 ug DNA | 486 EUR |
Nod2 ORF Vector (Mouse) (pORF) |
|||
| ORF051499 | ABM | 1.0 ug DNA | 607.2 EUR |
NOD2 ELISA Kit (Human) (OKCD02031) |
|||
| OKCD02031 | Aviva Systems Biology | 96 Wells | 997.2 EUR |
|
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.055 ng/mL |
|||
NOD2 ELISA Kit (Mouse) (OKCA01740) |
|||
| OKCA01740 | Aviva Systems Biology | 96 Wells | 1015.2 EUR |
|
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response (PubMed:22607974). Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages (PubMed:18511561).;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 3.9 pg/mL |
|||
NOD2 ELISA Kit (Human) (OKCA02128) |
|||
| OKCA02128 | Aviva Systems Biology | 96 Wells | 999.6 EUR |
|
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 6.25 pg/mL |
|||
NOD2 ELISA Kit (Human) (OKAN06319) |
|||
| OKAN06319 | Aviva Systems Biology | 96 Wells | 950.4 EUR |
|
Description: Description of target: This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.055 ng/mL |
|||
Anti-CARD15 / NOD2 (Internal) antibody |
|||
| STJ70992 | St John's Laboratory | 100 µg | 430.8 EUR |
h NOD2 inducible lentiviral particles |
|||
| LVP627 | GenTarget | 1x107 IFU/ml x 200ul | 541.2 EUR |
|
Description: Pre-made over-expression lentivirus for expressing human target: NOD2 (nucleotide-binding oligomerization domain containing 2), [alternative names: ACUG; BLAU; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_022162.1. It also contains a RFP-Blasticidin dual selection marker. |
|||
Nod2 sgRNA CRISPR Lentivector set (Rat) |
|||
| K6718501 | ABM | 3 x 1.0 ug | 406.8 EUR |
NOD2 3'UTR GFP Stable Cell Line |
|||
| TU065801 | ABM | 1.0 ml | 1636.8 EUR |
Nod2 3'UTR GFP Stable Cell Line |
|||
| TU264065 | ABM | 1.0 ml | Ask for price |
Nod2 3'UTR GFP Stable Cell Line |
|||
| TU164191 | ABM | 1.0 ml | Ask for price |
Nod2 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4411601 | ABM | 3 x 1.0 ug | 406.8 EUR |
NOD2 sgRNA CRISPR Lentivector set (Human) |
|||
| K1438601 | ABM | 3 x 1.0 ug | 406.8 EUR |
NOD2 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV285580 | ABM | 500 ng | 1399.2 EUR |
NOD2 Protein Vector (Rat) (pPB-C-His) |
|||
| PV285578 | ABM | 500 ng | 1399.2 EUR |
NOD2 Protein Vector (Rat) (pPB-N-His) |
|||
| PV285579 | ABM | 500 ng | 1399.2 EUR |
NOD2 Protein Vector (Rat) (pPM-C-His) |
|||
| PV285581 | ABM | 500 ng | 1399.2 EUR |
Polyclonal NOD2 / CARD15 Antibody (N-Terminus) |
|||
| APR02524G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 / CARD15 (N-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD2 / CARD15 Antibody (C-Terminus) |
|||
| APR02525G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 / CARD15 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
NOD2 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV205996 | ABM | 500 ng | 1278 EUR |
NOD2 Protein Vector (Human) (pPM-C-HA) |
|||
| PV104664 | ABM | 500 ng | 973.2 EUR |
NOD2 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV205994 | ABM | 500 ng | 1278 EUR |
NOD2 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV205995 | ABM | 500 ng | 1278 EUR |
NOD2 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV205997 | ABM | 500 ng | 1278 EUR |
NOD2 Protein Vector (Human) (pPB-C-His) |
|||
| PV104662 | ABM | 500 ng | 973.2 EUR |
NOD2 Protein Vector (Human) (pPB-N-His) |
|||
| PV104663 | ABM | 500 ng | 973.2 EUR |
NOD2 Protein Vector (Human) (pPM-C-His) |
|||
| PV104665 | ABM | 500 ng | 973.2 EUR |
NOD2 3'UTR Luciferase Stable Cell Line |
|||
| TU015801 | ABM | 1.0 ml | 1636.8 EUR |
Nod2 3'UTR Luciferase Stable Cell Line |
|||
| TU114191 | ABM | 1.0 ml | Ask for price |
Nod2 3'UTR Luciferase Stable Cell Line |
|||
| TU214065 | ABM | 1.0 ml | Ask for price |
Nod2 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K6718502 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K6718503 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K6718504 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K4411602 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K4411603 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K4411604 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD2 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1438602 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD2 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1438603 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD2 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1438604 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD2 Chemi-Luminescent ELISA Kit (Human) (OKCD03832) |
|||
| OKCD03832 | Aviva Systems Biology | 96 Wells | 1185.6 EUR |
|
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages .;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.0412 ng/mL |
|||
Polyclonal Goat Anti-CARD15 / NOD2 (Internal) Antibody |
|||
| APG00059G | Leading Biology | 0.1mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-CARD15 / NOD2 (Internal) . This antibody is tested and proven to work in the following applications: |
|||
NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV645601 | ABM | 1.0 ug DNA | 1626 EUR |
NOD2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV645605 | ABM | 1.0 ug DNA | 1626 EUR |
NOD2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV645606 | ABM | 1.0 ug DNA | 1626 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K6718505 | ABM | 3 x 1.0 ug | 451.2 EUR |
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody |
|||
| abx235781-100ug | Abbexa | 100 ug | 661.2 EUR |
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody |
|||
| 20-abx114240 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody |
|||
| 20-abx302321 | Abbexa |
|
|
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K4411605 | ABM | 3 x 1.0 ug | 451.2 EUR |
NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K1438605 | ABM | 3 x 1.0 ug | 451.2 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K6718506 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K6718507 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K6718508 | ABM | 1.0 ug DNA | 200.4 EUR |
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (HRP) |
|||
| 20-abx316579 | Abbexa |
|
|
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K4411606 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K4411607 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K4411608 | ABM | 1.0 ug DNA | 200.4 EUR |
NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K1438606 | ABM | 1.0 ug DNA | 200.4 EUR |
NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K1438607 | ABM | 1.0 ug DNA | 200.4 EUR |
NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K1438608 | ABM | 1.0 ug DNA | 200.4 EUR |
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (FITC) |
|||
| 20-abx316580 | Abbexa |
|
|
NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV645602 | ABM | 1.0 ug DNA | 1626 EUR |
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (Biotin) |
|||
| 20-abx316581 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) Antibody |
|||
| 20-abx211027 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) Antibody |
|||
| 20-abx339338 | Abbexa |
|
|
NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV645603 | ABM | 1.0 ug DNA | 1695.6 EUR |
NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV645604 | ABM | 1.0 ug DNA | 1695.6 EUR |
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) CLIA Kit |
|||
| 20-abx190892 | Abbexa |
|
|
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit |
|||
| SCK295Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 6777.36 EUR |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit |
|||
| SCK295Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 663.31 EUR |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit |
|||
| SCK295Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 896.16 EUR |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit |
|||
| SCK295Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3672.72 EUR |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) CLIA Kit |
|||
| 4-SCK295Hu | Cloud-Clone |
|
|
|
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)Tissue homogenates, cell lysates and other biological fluids |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
| 20-abx258642 | Abbexa |
|
|
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 ELISA Kit (NOD2) |
|||
| RK01942 | Abclonal | 96 Tests | 625.2 EUR |
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
| SEK295Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5677.8 EUR |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
| SEK295Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 572.76 EUR |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
| SEK295Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 766.8 EUR |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
| SEK295Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3090.6 EUR |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
| 4-SEK295Hu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) ELISA kit |
|||
| CSB-EL015915HU-24T | Cusabio | 1 plate of 24 wells | 198 EUR |
|
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) in samples from serum, plasma, asciticfluid, tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) ELISA kit |
|||
| 1-CSB-EL015915HU | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) in samples from serum, plasma, asciticfluid, tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
ELISA kit for Human NOD2 (Nucleotide Binding Oligomerization Domain Containing Protein 2) |
|||
| ELK5352 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
|
Description: A sandwich ELISA kit for detection of Nucleotide Binding Oligomerization Domain Containing Protein 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Nod3l/ Rat Nod3l ELISA Kit |
|||
| ELI-11062r | Lifescience Market | 96 Tests | 1063.2 EUR |
NOD1 siRNA |
|||
| 20-abx926109 | Abbexa |
|
|
NOD1 siRNA |
|||
| 20-abx926110 | Abbexa |
|
|
NOD1 Peptide |
|||
| 5947P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (CT) NOD1 peptide |
|||
NOD3 Peptide |
|||
| 5949P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (IN) NOD3 peptide |
|||
NOD4 Peptide |
|||
| 5951P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (NT) NOD4 peptide |
|||
NOD5 Peptide |
|||
| 5953P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (NT) NOD5 peptide |
|||
NOD6 Peptide |
|||
| 5955P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (NT) NOD6 peptide |
|||
NOD1 Rabbit pAb |
|||
| A1246-100ul | Abclonal | 100 ul | 369.6 EUR |
NOD1 Rabbit pAb |
|||
| A1246-200ul | Abclonal | 200 ul | 550.8 EUR |
NOD1 Rabbit pAb |
|||
| A1246-20ul | Abclonal | 20 ul | 219.6 EUR |
NOD1 Rabbit pAb |
|||
| A1246-50ul | Abclonal | 50 ul | 267.6 EUR |
NOD1 Peptide |
|||
| 42-460P | ProSci | 0.1 mg | 405.6 EUR |
|
Description: (CT) NOD1 Peptide |
|||
NOD1 Antibody |
|||
| 5947-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: NOD1 Antibody: NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-κB. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. |
|||
NOD1 Antibody |
|||
| 5947-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: NOD1 Antibody: NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-κB. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. |
|||
NOD3 Antibody |
|||
| 5949-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: NOD3 Antibody: NOD3 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD3 also known as NLR family CARD containing 3 (NLRC3), is predominantly expressed in the immune system, particularly in T lymphocytes, and its expression is strongly down-regulated following stimulation of the T-cell receptor complex and CD28, suggesting that NOD3 plays a role in attenuating the activation of T cells. NOD3 inhibits NF-kappaB, AP-1 and NFAT transcriptional activation in Jurkat T cells downstream of CD3/CD28 stimulation or treatment with PMA/ionomycin and decreases IL-2 and CD25 mRNA induction in activated cells. |
|||
NOD3 Antibody |
|||
| 5949-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: NOD3 Antibody: NOD3 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD3 also known as NLR family CARD containing 3 (NLRC3), is predominantly expressed in the immune system, particularly in T lymphocytes, and its expression is strongly down-regulated following stimulation of the T-cell receptor complex and CD28, suggesting that NOD3 plays a role in attenuating the activation of T cells. NOD3 inhibits NF-kappaB, AP-1 and NFAT transcriptional activation in Jurkat T cells downstream of CD3/CD28 stimulation or treatment with PMA/ionomycin and decreases IL-2 and CD25 mRNA induction in activated cells. |
|||
NOD4 Antibody |
|||
| 5951-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: NOD4 Antibody: NOD4 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD4 contains a CARD-like domain, a central NOD domain and a large LRR region. NOD4, an IFN-gamma-inducible nuclear protein, plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms. As a key negative regulator of NF-κB and type I interferon signaling, NOD4 may be a useful target for manipulating immune responses against infectious or inflammation-associated diseases, including cancer. |
|||
NOD4 Antibody |
|||
| 5951-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: NOD4 Antibody: NOD4 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD4 contains a CARD-like domain, a central NOD domain and a large LRR region. NOD4, an IFN-gamma-inducible nuclear protein, plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms. As a key negative regulator of NF-κB and type I interferon signaling, NOD4 may be a useful target for manipulating immune responses against infectious or inflammation-associated diseases, including cancer. |
|||
NOD5 Antibody |
|||
| 5953-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: NOD5 Antibody: NOD5, also known as NLRX1, is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD5 localizes to the mitochondrial outer membrane and interacts with the virus-induced signaling adapter protein VISA. Unlike a subset of NOD-like receptors (NLRs) such as NOD1 and NOD2 which trigger pro-inflammatory cascades, and other NLRs that induce the caspase 1 inflammasome in response to immune challenges, NOD5 amplifies NF-κB and JNK pathways by inducing reactive oxygen species production. |
|||
NOD5 Antibody |
|||
| 5953-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: NOD5 Antibody: NOD5, also known as NLRX1, is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD5 localizes to the mitochondrial outer membrane and interacts with the virus-induced signaling adapter protein VISA. Unlike a subset of NOD-like receptors (NLRs) such as NOD1 and NOD2 which trigger pro-inflammatory cascades, and other NLRs that induce the caspase 1 inflammasome in response to immune challenges, NOD5 amplifies NF-κB and JNK pathways by inducing reactive oxygen species production. |
|||
NOD6 Antibody |
|||
| 5955-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: NOD6 Antibody: NOD6, also known as NALP9, is a member of the NALP family, a group of proteins that typically contain a NACHT domain, a NACHT-associated domain (NAD), a C-terminal leucine-rich repeat (LRR) region, and an N-terminal pyrin domain (PYD) and are involved in inflammation and innate immune defense. The bovine NOD6, which has 76% homology to its human counterpart, has been suggested to be an oocyte marker gene. In adult tissues, NALP9 mRNA is expressed exclusively in ovary and testis. |
|||
NOD6 Antibody |
|||
| 5955-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: NOD6 Antibody: NOD6, also known as NALP9, is a member of the NALP family, a group of proteins that typically contain a NACHT domain, a NACHT-associated domain (NAD), a C-terminal leucine-rich repeat (LRR) region, and an N-terminal pyrin domain (PYD) and are involved in inflammation and innate immune defense. The bovine NOD6, which has 76% homology to its human counterpart, has been suggested to be an oocyte marker gene. In adult tissues, NALP9 mRNA is expressed exclusively in ovary and testis. |
|||
NOD1 antibody |
|||
| 70R-13231 | Fitzgerald | 100 ul | 548.4 EUR |
|
Description: Affinity purified Rabbit polyclonal NOD1 antibody |
|||
NOD1 Antibody |
|||
| 25174-100ul | SAB | 100ul | 468 EUR |
NOD3 Antibody |
|||
| 25175-100ul | SAB | 100ul | 468 EUR |
NOD4 Antibody |
|||
| 25176-100ul | SAB | 100ul | 468 EUR |
NOD5 Antibody |
|||
| 25177-100ul | SAB | 100ul | 468 EUR |
NOD6 Antibody |
|||
| 25178-100ul | SAB | 100ul | 468 EUR |
Nod1 antibody |
|||
| 22788-100ul | SAB | 100ul | 468 EUR |
NOD1 Antibody |
|||
| ABD6378 | Lifescience Market | 100 ug | 525.6 EUR |
NOD1 Antibody |
|||
| 32256-100ul | SAB | 100ul | 302.4 EUR |
NOD1 Antibody |
|||
| CSB-PA015914KA01HU- | Cusabio | each | 402 EUR |
|
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
|||
NOD1 Antibody |
|||
| CSB-PA015914KA01HU-100ul | Cusabio | 100ul | 466.8 EUR |
|
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
|||
NOD1 Antibody |
|||
| DF6378 | Affbiotech | 200ul | 420 EUR |
NOD1 Antibody |
|||
| 1-CSB-PA047815 | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200 |
|||
NOD1 Antibody |
|||
| 1-CSB-PA876477 | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200 |
|||
NOD1 Antibody |
|||
| F54615-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
|
Description: This gene encodes a member of the NOD (nucleotide-binding oligomerization domain) family. This member is a cytosolic protein. It contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. Multiple alternatively spliced transcript variants differring in the 5' UTR have been described, but the full-length nature of these variants has not been determined. |
|||
NOD1 Antibody |
|||
| F54615-0.4ML | NSJ Bioreagents | 0.4 ml | 322.15 EUR |
|
Description: This gene encodes a member of the NOD (nucleotide-binding oligomerization domain) family. This member is a cytosolic protein. It contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. Multiple alternatively spliced transcript variants differring in the 5' UTR have been described, but the full-length nature of these variants has not been determined. |
|||
NOD1 Antibody |
|||
| RQ5831 | NSJ Bioreagents | 100 ug | 356.15 EUR |
|
Description: Nucleotide-binding oligomerization domain-containing protein 1, also known as CARD4, is a protein receptor that in humans is encoded by the NOD1 gene. NOD1 is a member of NOD-like receptor protein family and is a close relative of NOD2. NOD1 is mapped to 7p14.3. It recognizes bacterial molecules and stimulates an immune reaction. NOD1 protein contains a caspase recruitment domain (CARD). This gene is an intracellular pattern recognition receptor, which is similar in structure to resistant proteins of plants, and mediates innate and acquired immunity by recognizing bacterial molecules containing D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety. What wore, it has been shown that NOD1 can sense cytosolic microbial products by monitoring the activation state of small Rho GTPases. |
|||
NOD1 Antibody |
|||
| RQ6083 | NSJ Bioreagents | 100 ug | 356.15 EUR |
|
Description: Nucleotide-binding oligomerization domain-containing protein 1, also known as CARD4, is a protein receptor that in humans is encoded by the NOD1 gene. NOD1 is a member of NOD-like receptor protein family and is a close relative of NOD2. NOD1 is mapped to 7p14.3. It recognizes bacterial molecules and stimulates an immune reaction. NOD1 protein contains a caspase recruitment domain (CARD). This gene is an intracellular pattern recognition receptor, which is similar in structure to resistant proteins of plants, and mediates innate and acquired immunity by recognizing bacterial molecules containing D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety. What wore, it has been shown that NOD1 can sense cytosolic microbial products by monitoring the activation state of small Rho GTPases. |
|||
Nod1 Antibody |
|||
| R31707 | NSJ Bioreagents | 100 ug | 356.15 EUR |
|
Description: Nucleotide-binding oligomerization domain-containing protein 1, also known as CARD4, is a protein receptor that in humans is encoded by the NOD1 gene. It is a member of NOD-like receptor protein family and is a close relative of Nod2. It recognizes bacterial molecules and stimulates an immune reaction. Nod1 contains a caspase recruitment domain (CARD). This gene is an intracellular pattern recognition receptor, which is similar in structure to resistant proteins of plants, and mediates innate and acquired immunity by recognizing bacterial molecules containing D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety. Additionally, it has been shown that Nod1 can sense cytosolic microbial products by monitoring the activation state of small Rho GTPases. |
|||
NOD1 Antibody |
|||
| R33706-100UG | NSJ Bioreagents | 100 ug | 339.15 EUR |
|
Description: Additional name(s) for this target protein: Nucleotide-binding oligomerization domain containing 1 |
|||
Mouse Nod1 ELISA KIT |
|||
| ELI-35306m | Lifescience Market | 96 Tests | 1038 EUR |
Human NOD1 ELISA KIT |
|||
| ELI-46124h | Lifescience Market | 96 Tests | 988.8 EUR |
NOD1 ELISA KIT|Human |
|||
| EF005372 | Lifescience Market | 96 Tests | 826.8 EUR |
Nod1 ORF Vector (Rat) (pORF) |
|||
| ORF071394 | ABM | 1.0 ug DNA | 607.2 EUR |
Mouse Nod1 Antibody |
|||
| abx030859-400ul | Abbexa | 400 ul | 627.6 EUR |
Mouse Nod1 Antibody |
|||
| abx030859-80l | Abbexa | 80 µl | 343.2 EUR |
NOD1 cloning plasmid |
|||
| CSB-CL896866HU-10ug | Cusabio | 10ug | 279.6 EUR |
|
Description: A cloning plasmid for the NOD1 gene. |
|||
NOD1 ORF Vector (Human) (pORF) |
|||
| ORF007140 | ABM | 1.0 ug DNA | 114 EUR |
Nod1 ORF Vector (Mouse) (pORF) |
|||
| ORF051497 | ABM | 1.0 ug DNA | 607.2 EUR |
Nod1 ORF Vector (Mouse) (pORF) |
|||
| ORF051498 | ABM | 1.0 ug DNA | 607.2 EUR |
NOD1 3'UTR GFP Stable Cell Line |
|||
| TU065800 | ABM | 1.0 ml | 1825.2 EUR |
Nod1 3'UTR GFP Stable Cell Line |
|||
| TU264064 | ABM | 1.0 ml | Ask for price |
Nod1 3'UTR GFP Stable Cell Line |
|||
| TU164190 | ABM | 1.0 ml | Ask for price |
Human NOD1 shRNA Plasmid |
|||
| 20-abx957041 | Abbexa |
|
|
Mouse NOD1 shRNA Plasmid |
|||
| 20-abx979820 | Abbexa |
|
|
NOD1 Blocking Peptide |
|||
| DF6378-BP | Affbiotech | 1mg | 234 EUR |
nod3l 3'UTR GFP Stable Cell Line |
|||
| TU264066 | ABM | 1.0 ml | Ask for price |
Anti-NLRX1/Nod9 Antibody |
|||
| A04980-1 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for NLRX1 Antibody (NLRX1) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
Anti-CARD4/NOD1 Antibody |
|||
| PB9294 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-NLRX1 / NOD9 antibody |
|||
| STJ72177 | St John's Laboratory | 100 µg | 430.8 EUR |
Polyclonal NOD1 Antibody |
|||
| APR06661G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD3 Antibody |
|||
| APR06662G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD3 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD4 Antibody |
|||
| APR06663G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD4 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD5 Antibody |
|||
| APR06664G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD5 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD6 Antibody |
|||
| APR06665G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD6 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD1 Antibody |
|||
| APR03070G | Leading Biology | 0.05ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 . This antibody is tested and proven to work in the following applications: |
|||
NOD1 Conjugated Antibody |
|||
| C32256 | SAB | 100ul | 476.4 EUR |
NOD1 ELISA Kit (Human) (OKEH08039) |
|||
| OKEH08039 | Aviva Systems Biology | 96 Wells | 1075.2 EUR |
|
Description: Description of target: This gene encodes a member of the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family of proteins. The encoded protein plays a role in innate immunity by acting as a pattern-recognition receptor (PRR) that binds bacterial peptidoglycans and initiates inflammation. This protein has also been implicated in the immune response to viral and parasitic infection. Major structural features of this protein include an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. Mutations in this gene are associated with asthma, inflammatory bowel disease, Behcet disease and sarcoidosis in human patients.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078 ng/mL |
|||
NOD1 ELISA Kit (Mouse) (OKEH08040) |
|||
| OKEH08040 | Aviva Systems Biology | 96 Wells | 1310.4 EUR |
|
Description: Description of target: ;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Competitive ELISA;Sensitivity: 0.096ng/mL |
|||
NOD1 ELISA Kit (Human) (OKCA00743) |
|||
| OKCA00743 | Aviva Systems Biology | 96 Wells | 999.6 EUR |
|
Description: Description of target: Enhances caspase-9-mediated apoptosis. Induces NF-kappa-B activity via RIPK2 and IKK-gamma. Confers responsiveness to intracellular bacterial lipopolysaccharides (LPS). Forms an intracellular sensing system along with ARHGEF2 for the detection of microbial effectors during cell invasion by pathogens. Required for RHOA and RIPK2 dependent NF-kappa-B signaling pathway activation upon S.flexneri cell invasion. Involved not only in sensing peptidoglycan (PGN)-derived muropeptides but also in the activation of NF-kappa-B by Shigella effector proteins IpgB2 and OspB. Recruits NLRP10 to the cell membrane following bacterial infection.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 3.9 pg/mL |
|||
NOD1 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV285576 | ABM | 500 ng | 1429.2 EUR |
NOD1 Protein Vector (Rat) (pPB-C-His) |
|||
| PV285574 | ABM | 500 ng | 1429.2 EUR |
NOD1 Protein Vector (Rat) (pPB-N-His) |
|||
| PV285575 | ABM | 500 ng | 1429.2 EUR |
NOD1 Protein Vector (Rat) (pPM-C-His) |
|||
| PV285577 | ABM | 500 ng | 1429.2 EUR |
NOD1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV028559 | ABM | 500 ng | 394.8 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV205988 | ABM | 500 ng | 1278 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV205992 | ABM | 500 ng | 1278 EUR |
Polyclonal NOD1 Antibody (C-term) |
|||
| APR03618G | Leading Biology | 0.1ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (C-term). This antibody is tested and proven to work in the following applications: |
|||
NOD1 Protein Vector (Human) (pPB-C-His) |
|||
| PV028557 | ABM | 500 ng | 394.8 EUR |
Data evaluation was performed utilizing Statistical Package for Social Sciences model 20.Left aspect predominated with 88 (63.7%) and extension kind was frequent in 135 (97.8%). Thirteen (9.4%) sufferers had been initially managed by conventional bonesetters. A complete of 138 kids underwent operative fixation with imply age of seven.47 years and gender ratio of two:1 boy to woman.
Fall from cliff, ladders and rooftops had been the prevailing explanation for harm 73 (52.8%). Average time between harm and surgical procedure was 5.2 days. Closed discount was performed in 100 (72.4%) sufferers whereas open discount was crucial in 38 (27.5%) sufferers.Closed extension kind pediatric supracondylar fracture was frequent in this examine. Fall from cliff, rooftop and ladder are the most important explanation for fracture. Delayed presentation and preliminary administration of the fracture by the standard bonesetters makes supracondylar fracture tougher in useful resource restricted setting like ours.
